Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas
Dimou, Maria, Papageorgiou, Sotirios G., Stavroyianni, Niki, Katodritou, Eirini, Tsirogianni, Maria, Kalpadakis, Christina, Banti, Anastasia, Arapaki, Maria, Iliakis, Theodoros, Bouzani, Maria, Verrou, Eugenia, Spanoudakis, Emmanouil, Giannouli, Stavroula, Marinakis, Theodoros, Mandala, Evdokia, Mparmparousi, Despoina, Sachanas, Sotirios, Dalekou‐Tsolakou, Maria, Hatzimichael, Eleftheria, Vadikolia, Chryssa, Violaki, Vasiliki, Poziopoulos, Christos, Tsirkinidis, Pantelis, Chatzileontiadou, Sofia, Vervessou, Elissavet, Ximeri, Maria, Sioni, Anastasia, Konstantinidou, Pavlina, Kyrtsonis, Marie‐Christine, Siakantaris, Marina P., Angelopoulou, Maria K., Pappa, Vassiliki, Konstantopoulos, Kostas, Panayiotidis, Panayiotis, Vassilakopoulos, Theodoros P.
Published in Hematological oncology (01.08.2021)
Published in Hematological oncology (01.08.2021)
Get full text
Journal Article